Home › Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management
 

Keywords :   


Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management

2016-01-11 06:07:38| Biotech - Topix.net

EQIS Capital Management decreased its stake in Alexion Pharmaceuticals, Inc. by 51.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,974 shares of the biopharmaceutical company's stock after selling 10,740 shares during the period.

Tags: management position capital decreased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »